Danaher plans its first AI-powered autonomous lab for early 2027, linking molecular design, robotic experiments and feedback into one loop

What changed

Danaher announced on October 7 that it plans to build its first AI-powered autonomous laboratory at Abcam, with scaled operation targeted for early 2027. The system connects AI-driven molecular design, robotic build-and-test workflows and feedback into a continuous design-make-test-learn loop for antibodies and other affinity reagents. Danaher targets up to 8x faster discovery and up to 10x greater annual reagent generation; those figures are company goals for the planned system rather than independent completed benchmarks.